Crafton Biotechnology Co., Ltd.
- Biotech or pharma, therapeutic R&D
Crafton Biotechnology is a privately-held mRNA drug developer with a pipeline of novel mRNA vaccines and therapeutics, powered by our suite of novel platform technologies including PureCap®, and chemical synthesis of mRNA. PureCap is the world's most advanced mRNA Cap2 analog, that allows for production of extremely pure, fully functional and fully capped mRNA, with higher protein expression, compared to industry standard. Our lead asset for COVID enters the clinic in 2026, and we have other programs in discovery stage.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}